The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...

Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...

Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...

With major changes coming to the Federal Employee Health Benefits (FEHB) plan, employees and retirees need to pay extra ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.

The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to ...

Anatara Lifesciences Ltd (AU:ANR) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...

The FDA has approved Eli Lillys Zepbound as the first weight-loss drug to treat obstructive sleep apnea, reshaping care for ...